NEU 2.88% $16.54 neuren pharmaceuticals limited

Neuren Media and Analyst Coverage, page-832

  1. 1,359 Posts.
    lightbulb Created with Sketch. 353
    I've got Daybue being administered to all 4,500 currently identified Retts patients in the USA by the end of 2027 in my DCF model. It's quite possible that by then there'll be at least as many more Retts patients in the USA that could be identified, given more widespread knowledge of the condition, and a known treatment for it. I could include more growth by another one or two hundred people per quarter beyond the end of 2027, but I think that is one of the conservative aspects of my DCF model - I have assumed no further growth beyond the currently known 4.500 people with the condition.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$16.54
Change
-0.490(2.88%)
Mkt cap ! $2.114B
Open High Low Value Volume
$16.94 $17.02 $16.38 $10.33M 620.5K

Buyers (Bids)

No. Vol. Price($)
1 5061 $16.52
 

Sellers (Offers)

Price($) Vol. No.
$16.62 1284 1
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.